April 23, 20215 min read, 1090 words
More than half Canada's AstraZeneca vaccine came from U.S. plant accused by FDA of quality-control problems
Published: April 23, 2021 | 5 min read, 1090 words
Close to two thirds of the AstraZeneca COVID-19 vaccine imported into Canada came from a U.S. factory that American authorities say was rife with quality-control issues, Health Canada confirmed Thursday. The U.S. Food and Drug Administration it will not allow the release of any v...